Abeta-IN-6 is an orally active compound exhibiting anti-inflammatory, antioxidant, and anti-oligomeric activities, with significant implications for Alzheimers disease (AD) research [1]. It effectively reduces the release of pro-inflammatory cytokines from microglia cells, promotes Nrf2 nuclear translocation, and impedes the formation of Abeta oligomers. Furthermore, Abeta-IN-6 demonstrates a stable neuroprotective effect by modulating redox-sensitive signaling pathways in an in vivo oxidative stress model.
Molecular Weight:
473.56
Formula:
C28H31N3O4
Target:
Nrf2|||Others|||Beta Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted
